A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Azithromycin reduces airway inflammation and improves forced expiratory volume in 1 s (FEV 1 ) in chronic rejection or bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). Azithromycin prophylaxis might prevent BOS. A double-blind randomised controlled trial of azithromycin (n = 40) or placebo (n = 43), initiated at discharge and administered three times a week for 2 yrs, was performed in 2005–2009 at the Leuven University Hospital (Leuven, Belgium). Primary end-points were BOS-free and overall survival 2 yrs after LTx; secondary end-points were acute rejection, lymphocytic bronchiolitis and pneumonitis rate, prevalence of pseudomonal airway colonisation or gastro-oesophageal reflux, and change in FEV 1 , airway and systemic inflammation over time. Patients developing BOS were assessed for change in FEV 1 with open-label azithromycin. BOS occurred less in patients receiving azithromycin: 12.5 versus 44.2% (p = 0.0017). BOS-free survival was better with azithromycin (hazard ratio 0.27, 95% CI 0.092–0.816; p = 0.020). Overall survival, acute rejection, lymphocytic bronchiolitis, pneumonitis, colonisation and reflux were comparable between groups. Patients receiving azithromycin demonstrated better FEV 1 (p = 0.028), and lower airway neutrophilia (p = 0.015) and systemic C-reactive protein levels (p = 0.050) over time. Open-label azithromycin for BOS improved FEV 1 in 52.2% patients. No serious adverse events were noted. Azithromycin prophylaxis attenuates local and systemic inflammation, improves FEV 1 and reduces BOS 2 yrs after LTx.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
Stewart, S., Fishbein, M. C., Snell, G. I., Berry, G. J., Boehler, A., Burke, M. M., Glanville, A., Gould, F. K., Magro, C., Marboe, C. C., et al. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.10.017 · Cited by 2,442
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
Estenne, M., Maurer, J. R., Boehler, A., Egan, J. J., Frost, A., Hertz, M., Mallory, G. B., Snell, G. I., & Yousem, S. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00398-4 · Cited by 1,274
Transplantation 50 Years Later — Progress, Challenges, and Promises
Sayegh, M. H., & Carpenter, C. B. (2004) · New England Journal of Medicine · doi:10.1056/nejmon043418 · Cited by 425
Burke, C. M., Theodore, J., Dawkins, K. D., Yousem, S. A., Blank, N., Billingham, M. E., Van Kessel, A., Jamieson, S. W., Oyer, P. E., Baldwin, J. C., et al. (1984) · Chest · doi:10.1378/chest.86.6.824 · Cited by 404
Christie, J. D., Edwards, L. B., Aurora, P., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., Taylor, D. O., Kucheryavaya, A. Y., & Hertz, M. I. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.08.004 · Cited by 333
Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study
Gerhardt, S. G., McDyer, J. F., Girgis, R. E., Conte, J. V., Yang, S. C., & Orens, J. B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200212-1424bc · Cited by 306
Verleden, G. M., Vanaudenaerde, B. M., Dupont, L. J., & Van Raemdonck, D. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200601-071oc · Cited by 296
Self-citationBlondeau, K., Mertens, V., Vanaudenaerde, B. A., Verleden, G. M., Van Raemdonck, D. E., Sifrim, D., & Dupont, L. J. (2008) · European Respiratory Journal · doi:10.1183/09031936.00064807 · Cited by 285
Self-citationAzithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome
Yates, B., Murphy, D. M., Forrest, I. A., Ward, C., Rutherford, R. M., Fisher, A. J., Lordan, J. L., Dark, J. H., & Corris, P. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1537oc · Cited by 228
Spirometry in the evaluation of pulmonary function.
Morris, J. F. (1976) · PubMed · Cited by 220
Long-Term Azithromycin for Bronchiolitis Obliterans Syndrome After Lung Transplantation
Gottlieb, J., Szangolies, J., Koehnlein, T., Golpon, H., Simon, A., & Welte, T. (2008) · Transplantation · doi:10.1097/01.tp.0000295981.84633.bc · Cited by 218
Chronic Lung Allograft Rejection: Mechanisms and Therapy
Belperio, J. A., Weigt, S. S., Fishbein, M. C., & Lynch, J. P. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200807-073go · Cited by 205
Transplantation — A Medical Miracle of the 20th Century
Morris, P. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048256 · Cited by 204
Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators
Giamarellos-Bourboulis, E. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.001 · Cited by 185
Vanaudenaerde, B. M., Meyts, I., Vos, R., Geudens, N., De Wever, W., Verbeken, E. K., Van Raemdonck, D. E., Dupont, L. J., & Verleden, G. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00134307 · Cited by 163
Self-citationJain, R., Hachem, R. R., Morrell, M. R., Trulock, E. P., Chakinala, M. M., Yusen, R. D., Huang, H. J., Mohanakumar, T., Patterson, G. A., & Walter, M. J. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.12.003 · Cited by 132
Lin, H., Kauffman, H. M., McBride, M., Davies, D. B., Rosendale, J. D., Smith, C. M., Edwards, E. B., Daily, O. P., Kirklin, J. K., Shield, C. F., et al. (1998) · JAMA · doi:10.1001/jama.280.13.1153 · Cited by 104
Sato, M., & Keshavjee, S. H. (2008) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2008.05.002 · Cited by 95
Bronchiolitis Obliterans Syndrome
Scott, A. I. R., Sharples, L. D., & Stewart, S. (2005) · Drugs · doi:10.2165/00003495-200565060-00004 · Cited by 83
Obliterative bronchiolitis following lung transplantation: from old to new concepts?
Verleden, G. M., Vos, R., Vleeschauwer, S. I. D., Willems‐Widyastuti, A., Verleden, S. E., Dupont, L., Raemdonck, D. E. V., & Vanaudenaerde, B. M. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.00872.x · Cited by 65
Self-citationImmunosuppression for Lung Transplantation
Snell, G. I., & Westall, G. P. (2007) · Drugs · doi:10.2165/00003495-200767110-00002 · Cited by 57
Evidence for immunosuppression in lung transplantation
Hopkins, P. M.-A., & McNeil, K. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32831040bf · Cited by 36
Borro, J. M., Bravo, C., Solé, A., Usetti, P., Zurbano, F., Lama, R., de la Torre, M., Román, A., Pastor, A., Laporta, R., et al. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.06.071 · Cited by 34
Cited by
Verleden, G. M., Glanville, A. R., Lease, E. D., Fisher, A. J., Calabrese, F., Corris, P. A., Ensor, C. R., Gottlieb, J., Hachem, R. R., Lama, V., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.03.009 · Cited by 952
Self-citationAzithromycin: Mechanisms of action and their relevance for clinical applications
Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.003 · Cited by 661
Self-citationMeyer, K. C., Raghu, G., Verleden, G. M., Corris, P. A., Aurora, P., Wilson, K. C., Brozek, J., Glanville, A. R., & the ISHLT/ATS/ERS BOS Task Force Committee (2014) · European Respiratory Journal · doi:10.1183/09031936.00107514 · Cited by 555
Self-citationA new classification system for chronic lung allograft dysfunction
Verleden, G. M., Raghu, G., Meyer, K. C., Glanville, A. R., & Corris, P. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.10.022 · Cited by 503
Self-citationCytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375
Metadata
- Authors
- Vos, R., Vanaudenaerde, B. M., Verleden, S. E., De Vleeschauwer, S. I., Willems-Widyastuti, A., Van Raemdonck, D. E., Schoonis, A., Nawrot, T. S., Dupont, L. J., & Verleden, G. M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2010-06-18
- Volume
- 37
- Issue
- 1
- Pages
- 164-172
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2115591184
- Cited by
- 268
- References
- 25
- FWCI
- 22.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.